| Literature DB >> 35136665 |
Tan Pei Pei1, Nor Hafizah Ahmad1, Noor Haslina Mohd Noor2.
Abstract
Para-Bombay blood phenotype is a rare blood group with limited cases reported worldwide. This blood group is characterized by the absence of ABH antigen on red blood cells but presence of ABH secretor substances in the body secretion. This rare phenotype is usually misinterpreted as O and may endanger the patient if urgent blood transfusion is required. A mother who was labelled as group O Rh D positive during antenatal follow-up was found to have ABO discrepancy during delivery. The newborn was admitted for extremely premature delivery at 25 weeks. As the baby required transfusion, problem arose during cross matching with the mother's sample. It was found that the mother was group O Rh D positive in forward grouping. However, the reverse grouping showed the presence of reaction (2+) in O cells. The baby was grouped as O Rh D positive. As transfusion was urgently needed due to baby's unstable condition, group O Rh D positive packed cell was found compatible with baby's serum, subsequently transfused. Bombay blood donor was contacted, and the donated blood was sent to the hospital for further management. Further investigations were performed, indicating that the mother is para-Bombay A. Due to recent transfusion to baby, we suggested to repeat baby's blood group after the baby is one year old. Para-Bombay was usually mislabelled as O if the sample was not tested with O cell in reverse grouping. Additional tests may be needed during antenatal follow-up to prevent complications during delivery, which requires emergency blood transfusion. The OMJ is Published Bimonthly and Copyrighted 2022 by the OMSB.Entities:
Keywords: Blood Grouping; Blood Transfusion; Delivery; Malaysia
Year: 2022 PMID: 35136665 PMCID: PMC8807886 DOI: 10.5001/omj.2021.45
Source DB: PubMed Journal: Oman Med J ISSN: 1999-768X
Tests performed for identification of mother’s blood group in an East Coast tertiary hospital.
| Test | Finding | Interpretation |
|---|---|---|
| Forward grouping[ | ||
| Anti-A | 0 | O Rh D positive |
| Anti-B | 0 | |
| Anti-A,B | 0 | |
| Anti-D | 4+ | |
| Reverse grouping[ | ||
| A cells | 4+ | Presence of extra antibodies |
| B cells | 4+ | |
| O cells | 2+ | |
| Antibody screening | 1+ (all 3 panels) | |
| Antibody identification (11 panels) | ||
| Normal panels | 0 | Antibody only detected in enzyme- enhanced panels |
| Enzyme-enhanced panels | 1+ (cell 1 and 2) | |
Note: reaction for all tests ranged from 0 (no reaction) to 4+ (strongest reaction).
1Forward grouping: testing of known serum (anti-A, anti-B, anti-A,B, and anti-D) with patient’s red cells.
2Reverse grouping: testing of patient’s serum with known cells (A cells, B cells, and O cells).
Tests performed for identification of mother’s blood group in the National Blood Centre.
| Test | Finding | Interpretation |
|---|---|---|
| Forward grouping[ | ||
| Anti-A | 0 | O Rh D positive |
| Anti-B | 0 | |
| Anti-A,B | 0 | |
| Anti-D | 4+ | |
| Anti-H | 0 | H antigen negative |
| Reverse grouping[ | ||
| A cells | 4+ | Presence of extra antibodies |
| B cells | 4+ | |
| O cells | 4+ | |
| Direct antiglobulin test | 0 | |
| Antibody screening | 0 | |
| Antibody identification (11 panels) | ||
| Normal panels | 0 (for all 11 panels) | Antibody only detected in enzyme-enhanced panels |
| Enzyme-enhanced panels | Panagglutination (1+) | |
| Absorption elution test | ||
| A cell | 3+ | A and H antigen present on patient’s red cells |
| B cell | 0 | |
| O cell | 2+ | |
| Secretor status (saliva test) | ||
| A cells | 0 | A and H substance present in saliva |
| B cells | 4+ | |
| O cells | 0 | |
| Additional tests | ||
| Adult O cells | 4+ | Antibody reacting with I antigen |
| Cord O cells | 0 | |
Note: reaction for all tests ranged from 0 (no reaction) to 4+ (strongest reaction).
1Forward grouping: testing of known serum (anti-A, anti-B, anti-A,B, and anti-D) with patient’s red cells.
2Reverse grouping: testing of patient’s serum with known cells (A cells, B cells, and O cells).
Figure 1Flow of case summary.